- Home
- OGS vs TVTX Comparison
OGS vs TVTX Comparison
Compare OGS & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OGS | TVTX |
|---|---|---|
| Founded | 1906 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.3B |
| IPO Year | 2013 | 2013 |
Fundamental Metrics
Financial Performance| Metric | OGS | TVTX |
|---|---|---|
| Price | $80.41 | $66.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $89.00 | $40.62 |
| AVG Volume (30 Days) | 460.4K | ★ 1.6M |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | 11.76 | ★ 92.89 |
| EPS | ★ 2.78 | N/A |
| Revenue | ★ $2,578,005,000.00 | N/A |
| Revenue This Year | $12.51 | $44.76 |
| Revenue Next Year | N/A | $35.51 |
| P/E Ratio | $28.90 | ★ N/A |
| Revenue Growth | ★ 42.54 | N/A |
| 52 Week Low | $74.06 | $17.05 |
| 52 Week High | $90.78 | $66.38 |
Technical Indicators
Market Signals| Indicator | OGS | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.27 | 67.15 |
| Support Level | $75.93 | $53.76 |
| Resistance Level | $81.90 | $66.24 |
| Average True Range (ATR) | 1.47 | 2.16 |
| MACD | -0.02 | 0.31 |
| Stochastic Oscillator | 48.52 | 88.06 |
Price Performance
Historical ComparisonAbout OGS ONE Gas Inc.
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. It operates in one reportable business segment: regulated public utilities that deliver natural gas to residential, commercial, and transportation customers.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.